ヘルスケアセクターの米国株ランキング

ヘルスケアセクターの米国主要 19 銘柄を、実データで一覧。低PER・高成長・高収益・乖離（期待先行）の代表銘柄と、全銘柄の主要指標を並べています。

セクター内のリーダー

#	銘柄	時価総額	PER	PSR	ROE	売上YoY	営業益率	乖離
1	LLY Eli Lilly	$1.14T	42.8×	14.3×	102%	+48%	—	-27pt
2	JNJ Johnson & Johnson	$613.7B	29.2×	6.3×	26%	+7%	—	+26pt
3	ABBV AbbVie	$461.3B	73.1×	7.2×	—	+10%	38%	+15pt
4	UNH UnitedHealth	$381.8B	27.0×	0.8×	14%	+0%	7%	-17pt
5	MRK Merck	$319.6B	100.7×	4.8×	7%	+5%	—	-1pt
6	AMGN Amgen	$202.3B	23.1×	5.3×	92%	+10%	35%	-2pt
7	TMO Thermo Fisher	$189.7B	27.2×	4.1×	14%	+10%	17%	-8pt
8	ABT Abbott	$179.2B	28.6×	4.0×	12%	+8%	12%	-11pt
9	GILD Gilead Sciences	$162.8B	—	5.3×	-21%	+10%	-133%	+34pt
10	ISRG Intuitive Surgical	$150.5B	47.9×	13.6×	17%	+19%	34%	-23pt
11	PFE Pfizer	$138.4B	32.0×	2.2×	5%	+3%	—	-14pt
12	DHR Danaher	$137.9B	34.4×	5.5×	8%	+6%	18%	-12pt
13	VRTX Vertex Pharmaceuticals	$133.8B	30.4×	10.6×	24%	+12%	37%	-4pt
14	SYK Stryker	$125.3B	33.6×	4.8×	17%	+9%	25%	-12pt
15	MDT Medtronic	$109.2B	20.9×	2.9×	11%	+14%	18%	-3pt
16	ELV Elevance Health	$90.6B	18.3×	0.5×	11%	+1%	4%	-20pt
17	REGN Regeneron	$67.3B	15.5×	4.3×	14%	+17%	30%	-28pt
18	BSX Boston Scientific	$65.4B	17.8×	3.1×	16%	+8%	22%	-41pt
19	HIMS Hims & Hers Health	$8.5B	—	3.3×	-32%	+38%	-13%	-20pt

※ 数値は直近四半期末ベース（ROEはTTM、乖離=直近2年の株価CAGR−売上CAGR）。並び替え・絞り込みはスクリーナーで。